Inclisiran (Romanian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Inclisiran" in Romanian language version.
refsWebsite
Global rank
Romanian rank
low place
low place
1st place
1st place
low place
low place
low place
low place
doi.org (Global: 2nd place; Romanian: 3rd place)
- „A Highly Durable RNAi Therapeutic Inhibitor of PCSK9”. The New England Journal of Medicine. 376 (1): 41–51. ianuarie 2017. doi:10.1056/NEJMoa1609243. PMC 5778873
. PMID 27959715.
europa.eu (Global: 68th place; Romanian: 19th place)
ema.europa.eu
- „Leqvio: Pending EC decision”. European Medicines Agency (EMA). . Arhivat din original la . Accesat în . Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- „Leqvio EPAR”. European Medicines Agency. . Accesat în .
fiercebiotech.com (Global: low place; Romanian: low place)
- Taylor, Nick Paul (). „Medicines Company's PCSK9 drug hits phase 3 efficacy goals”. FierceBiotech.
nih.gov (Global: 4th place; Romanian: 4th place)
ncbi.nlm.nih.gov
- „A Highly Durable RNAi Therapeutic Inhibitor of PCSK9”. The New England Journal of Medicine. 376 (1): 41–51. ianuarie 2017. doi:10.1056/NEJMoa1609243. PMC 5778873 . PMID 27959715.
novartis.com (Global: low place; Romanian: low place)
- „Novartis acquires medicines company”. Novartis. Accesat în .
themedicinescompany.com (Global: low place; Romanian: low place)
- „The Medicines Company Announces Positive Topline Results from First Pivotal Phase 3 Trial of Inclisiran”. The Medicines Company. Accesat în .
web.archive.org (Global: 1st place; Romanian: 1st place)
- „Leqvio: Pending EC decision”. European Medicines Agency (EMA). . Arhivat din original la . Accesat în . Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
who.int (Global: 195th place; Romanian: 100th place)
- „Proposed INN: List 114” (PDF). WHO Drug Information. WHO. 29 (4): 531f. .